Your final report will detail the testing protocol used, drugs or combination therapies tested, and therapeutic response of each group of mouse cohorts over time, measured in terms of tumor volume. It will include actual MRI images of your tumor’s size as well as detailed histology images of structural cellular changes observed during the study. Armed and with this information, you and your treatment team can move forward with certainty – confident that the next round of therapy is the best available option for your cancer.1-4 View a sample report.

Das Thakur, M., Salangsang, F., Landman, A. et al. Modelling Vemurafenib Resistance in Melanoma Reveals a Strategy to Forestall Drug ResistanceNature. 2013; 494(7436): 251–255.
Walters DM, Stokes JB, Adair SJ, et al. Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human SpecimensPLoS One. 2013;8(10): e77065.
Killion JJ, Radinsky R, Fidler IJ. Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in MiceCancer Metastasis Rev. 1998-1999;17(3):279–284.
2013;8(10): e77065.
Qiu W, Su GH. Development of Orthotopic Pancreatic Tumor Mouse ModelsMol Biol. 2013; 980: 215-223.